RE: Going up11 Nov 2022 09:49
The chemo induced pain market is anticipated to rise from £1 billion this year to £3billion by 2027 in the US alone.
This cannabinoid target is about to go into the funded 236 paitent clinical trial. We are funded until Q4 2023 having around £8M cash at present. This could 6-7 bag on decent tolerated data and there is lots of human data out there already...!
Watch this space